Understanding how DNA repair affects tissue health in mice lacking a specific repair gene

Genotoxic stress response and mutagenesis in normal tissues of mice deficient in homology directed repair

['FUNDING_R01'] · TULANE UNIVERSITY OF LOUISIANA · NIH-11010787

This study is looking at how the missing Brca1 gene affects the health of tissues in mice when they face environmental challenges that can harm their DNA, helping us understand how different repair systems work to keep our cells safe from damage.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorTULANE UNIVERSITY OF LOUISIANA (nih funded)
Locations1 site (NEW ORLEANS, UNITED STATES)
Trial IDNIH-11010787 on ClinicalTrials.gov

What this research studies

This research investigates how the absence of a key DNA repair gene, Brca1, affects the health and integrity of tissues in mice when exposed to environmental stresses that damage DNA. By using genetically engineered mice that can lose this gene after development, the study aims to uncover the role of different DNA repair pathways in maintaining tissue viability and preventing mutations. The research will explore how various tissues respond to DNA damage and the interplay between different repair mechanisms, providing insights into the biological processes that protect against genetic damage.

Who could benefit from this research

Good fit: Ideal candidates for this research would be individuals with a genetic predisposition to conditions related to DNA repair deficiencies, such as those with BRCA1 mutations.

Not a fit: Patients without genetic predispositions to DNA repair deficiencies or those not affected by related conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding of DNA repair mechanisms, potentially informing treatments for conditions related to DNA damage, such as cancer.

How similar studies have performed: Previous research has shown success in understanding DNA repair mechanisms in various models, but this specific approach using inducible gene deletion in adult mammals is relatively novel.

Where this research is happening

NEW ORLEANS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.